Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Pasqualini

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2007
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6Yeny Martinez de la Torre, Chiara Buracchi, Elena M Borroni, et al.
Cell|July 2, 2019
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human TumorsAndrea Ponzetta, Roberta Carriero, Silvia Carnevale, et al.
Cell|February 14, 2015
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancerEduardo Bonavita, Stefania Gentile, Marcello Rubino, et al.
Cancer Immunology Research|June 30, 2026
Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironmentMarika Viatore, Rebecca Polidori, Anna Rita Putignano, et al.
Nature Immunology|April 27, 2021
Heme catabolism by tumor-associated macrophages controls metastasis formationFrancesca Maria Consonni, Augusto Bleve, Maria Grazia Totaro, et al.
Oncotarget|May 24, 2017
High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunityLuis Felipe Campesato, Ana Paula M Silva, Luna Cordeiro, et al.
Cancer Cell|February 16, 2013
Role of macrophage targeting in the antitumor activity of trabectedinGiovanni Germano, Roberta Frapolli, Cristina Belgiovine, et al.
Oncotarget|November 29, 2016
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantationErica Dander, Paola De Lorenzo, Barbara Bottazzi, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2007
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6Yeny Martinez de la Torre, Chiara Buracchi, Elena M Borroni, et al.
Cell|July 2, 2019
Neutrophils Driving Unconventional T Cells Mediate Resistance against Murine Sarcomas and Selected Human TumorsAndrea Ponzetta, Roberta Carriero, Silvia Carnevale, et al.
Cell|February 14, 2015
PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancerEduardo Bonavita, Stefania Gentile, Marcello Rubino, et al.
Cancer Immunology Research|June 30, 2026
Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironmentMarika Viatore, Rebecca Polidori, Anna Rita Putignano, et al.
Nature Immunology|April 27, 2021
Heme catabolism by tumor-associated macrophages controls metastasis formationFrancesca Maria Consonni, Augusto Bleve, Maria Grazia Totaro, et al.
Oncotarget|May 24, 2017
High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunityLuis Felipe Campesato, Ana Paula M Silva, Luna Cordeiro, et al.
Cancer Cell|February 16, 2013
Role of macrophage targeting in the antitumor activity of trabectedinGiovanni Germano, Roberta Frapolli, Cristina Belgiovine, et al.
Oncotarget|November 29, 2016
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantationErica Dander, Paola De Lorenzo, Barbara Bottazzi, et al.
Pageof 6